| Bioactivity | NXT-10796 is orally active, intestinally restricted EP4 receptor agonist[1]. |
| Name | NXT-10796 |
| Formula | C23H31N3O6 |
| Molar Mass | 445.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. St-Onge M, et al. Discovery of NXT-10796, an orally active, intestinally restricted EP4 agonist prodrug for the treatment of inflammatory bowel disease. Bioorg Med Chem Lett. 2023;91:129351. |